Public Employees Retirement System of Ohio Sells 4,480 Shares of Phibro Animal Health Corporation $PAHC

Public Employees Retirement System of Ohio reduced its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 33.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,879 shares of the company’s stock after selling 4,480 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Phibro Animal Health were worth $227,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Financial Management Professionals Inc. bought a new stake in shares of Phibro Animal Health in the 2nd quarter worth approximately $32,000. Cardinal Capital Management boosted its position in shares of Phibro Animal Health by 28.8% in the 2nd quarter. Cardinal Capital Management now owns 96,639 shares of the company’s stock worth $2,468,000 after purchasing an additional 21,629 shares in the last quarter. A&I Financial Services LLC bought a new stake in shares of Phibro Animal Health in the 2nd quarter worth approximately $750,000. Sowell Financial Services LLC boosted its position in shares of Phibro Animal Health by 2.9% in the 2nd quarter. Sowell Financial Services LLC now owns 95,242 shares of the company’s stock worth $2,432,000 after purchasing an additional 2,679 shares in the last quarter. Finally, Kings Path Partners LLC boosted its position in shares of Phibro Animal Health by 87.3% in the 2nd quarter. Kings Path Partners LLC now owns 20,600 shares of the company’s stock worth $526,000 after purchasing an additional 9,600 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 7,022 shares of the stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $40.26, for a total value of $282,705.72. Following the completion of the sale, the chief executive officer owned 31,338 shares in the company, valued at approximately $1,261,667.88. This represents a 18.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last ninety days, insiders sold 24,622 shares of company stock valued at $995,893. Corporate insiders own 50.13% of the company’s stock.

Phibro Animal Health Trading Down 1.4%

Shares of PAHC stock opened at $37.79 on Tuesday. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $41.57. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76. The firm has a market capitalization of $1.53 billion, a PE ratio of 32.03, a PEG ratio of 1.16 and a beta of 0.83. The stock has a fifty day simple moving average of $34.87 and a two-hundred day simple moving average of $27.40.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.05. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The business had revenue of $378.70 million during the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Wednesday, September 3rd. Phibro Animal Health’s dividend payout ratio is presently 40.68%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on PAHC. Bank of America upped their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research report on Friday, August 29th. JPMorgan Chase & Co. raised Phibro Animal Health from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $25.00 to $35.00 in a research report on Monday, July 7th. BNP Paribas raised Phibro Animal Health to a “hold” rating in a research report on Monday, June 16th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Phibro Animal Health in a research report on Saturday, September 27th. Finally, Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health has an average rating of “Hold” and an average price target of $28.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.